Eyasu H. Teshale, MD
Articles
August 13th 2019
Anne C. Moorman, MPH Jian Xing, PhD Loralee B. Rupp, MSE Stuart C. Gordon, MD Mei Lu, PhD Philip R. Spradling, MD Joseph A. Boscarino, PhD Mark A. Schmidt, PhD Yihe G. Daida, PhD Eyasu H. Teshale, MD for the CHeCS Investigators
Late hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.
April 17th 2014
Hepatitis B Virus Infection Testing and Prevalence Among Asian and Pacific Islanders
Vinutha Vijayadeva, PhD, MPH Philip R. Spradling, MD Anne C. Moorman, BSN, MPH Loralee B. Rupp, MS Mei Lu, PhD Stuart C. Gordon, MD Emily Henkle, PhD, MPH Joseph A. Boscarino, PhD, MPH Eyasu H. Teshale, MD Cynthia Nakasato, MD*
We examined the effect of country of origin on HBV testing and chronic HBV infection prevalence among APIs using data from Kaiser Permanente Hawaii.
Latest Updated Articles
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 20th 2024 | Updated: November 5th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
